Bayer Wins US Approval for New Drug Hyrnuo in Lung Cancer
Bayer AG won US approval for its new medicine Hyrnuo to treat a common form of lung cancer as the German company works to bolster its drug pipeline.
By Sonja Wind ยท Bloomberg
Bayer AG won US approval for its new medicine Hyrnuo to treat a common form of lung cancer as the German company works to bolster its drug pipeline.